We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+3.35%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$2.86B
AUM Growth
+$344M
Cap. Flow
+$315M
Cap. Flow %
11.01%
Top 10 Hldgs %
23.55%
Holding
1,809
New
745
Increased
318
Reduced
227
Closed
516

Sector Composition

Rank Sector Weight
1 Utilities 15.61%
2 Technology 12.98%
3 Industrials 12.91%
4 Consumer Discretionary 9.54%
5 Financials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SINA
676
DELISTED
Sina Corp
SINA
$481K 0.02%
+12,263
New +$500K
KEYS icon
677
Keysight
KEYS
$52.9B
$480K 0.02%
+4,932
New +$457K
TRN icon
678
Trinity Industries
TRN
$2.37B
$479K 0.02%
+24,343
New +$460K
EVRI
679
DELISTED
Everi Holdings
EVRI
$478K 0.02%
56,518
+42,039
+290% +$430K
QTS
680
DELISTED
QTS REALTY TRUST, INC.
QTS
$478K 0.02%
+9,300
New +$442K
TGI
681
DELISTED
Triumph Group
TGI
$477K 0.02%
+20,845
New +$477K
PLMR icon
682
Palomar
PLMR
$3.5B
$476K 0.02%
+12,084
New +$377K
FOXA icon
683
Fox Class A
FOXA
$29B
$472K 0.02%
+14,977
New +$518K
MAC icon
684
Macerich
MAC
$6.91B
$471K 0.02%
14,908
-5,264
-26% -$166K
BYD icon
685
Boyd Gaming
BYD
$5.89B
$470K 0.02%
19,641
+6,177
+46% +$156K
TMO icon
686
Thermo Fisher Scientific
TMO
$232B
$470K 0.02%
1,613
-31,329
-95% -$8.97M
EWBC icon
687
East-West Bancorp
EWBC
$17.7B
$468K 0.02%
+10,559
New +$464K
KWR icon
688
Quaker Houghton
KWR
$2.79B
$468K 0.02%
+2,960
New +$507K
XYL icon
689
Xylem
XYL
$26.7B
$468K 0.02%
+5,875
New +$462K
CNA icon
690
CNA Financial
CNA
$13.4B
$467K 0.02%
+9,484
New +$454K
AIR icon
691
AAR Corp
AIR
$5.42B
$466K 0.02%
11,300
-1,600
-12% -$67.2K
CCL icon
692
Carnival Corporation Ltd
CCL
$35.2B
$466K 0.02%
10,663
+1,563
+17% +$72.1K
ESS icon
693
Essex Property Trust
ESS
$18.9B
$465K 0.02%
+1,425
New +$445K
SHYF
694
DELISTED
The Shyft Group
SHYF
$465K 0.02%
+33,896
New +$413K
TW icon
695
Tradeweb Markets
TW
$22.9B
$465K 0.02%
12,579
-163,196
-93% -$7.21M
CADE
696
DELISTED
Cadence Bank
CADE
$464K 0.02%
+15,677
New +$447K
SCHL icon
697
Scholastic
SCHL
$760M
$463K 0.02%
+12,267
New +$431K
PS
698
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$463K 0.02%
27,540
-70,234
-72% -$1.51M
HEI icon
699
HEICO Corp
HEI
$49.3B
$462K 0.02%
+3,700
New +$506K
EVRG icon
700
Evergy
EVRG
$18.8B
$459K 0.02%
6,900
-86,636
-93% -$5.48M

Similar funds

Michael Gelband's Q3 2019 Portfolio in Review

As of Q3 2019, Michael Gelband held 1,809 positions worth $2.86B, up 14% from $2.51B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Michael Gelband deployed $315M of net new capital in Q3 2019, opening 745 new positions and adding to 318 existing holdings. Its largest new stake was iShares MSCI USA Momentum Factor ETF: 324,777 shares worth $38.7M.

By sector, the portfolio is most concentrated in Utilities at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $41.1M trimmed.

  • Michael Gelband's largest Q3 2019 buy was iShares MSCI USA Momentum Factor ETF: 324,777 shares worth $38.7M.
  • Michael Gelband added most to Aramark in Q3 2019, an estimated $65.8M increase.
  • Michael Gelband's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $41.1M.
  • Michael Gelband fully exited Altaba Inc in Q3 2019, selling an estimated $68.3M.
  • Michael Gelband's ten largest holdings make up 24% of its $2.86B portfolio in Q3 2019.
  • Michael Gelband opened 745 new positions and closed 516 in Q3 2019.
  • Michael Gelband's portfolio value rose 14% quarter-over-quarter to $2.86B.

Based on ExodusPoint Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.